| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000026260 |
| Receipt No. | R000027885 |
| Official scientific title of the study | Prospective cohort study on patients of pancreatic cancer performed EUSFNA |
| Date of disclosure of the study information | 2017/02/22 |
| Last modified on | 2018/03/08 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Prospective cohort study on patients of pancreatic cancer performed EUSFNA | |
| Title of the study (Brief title) | Prospective cohort study on patients of pancreatic cancer performed EUSFNA | |
| Region |
|
|
| Condition | ||
| Condition | Pancreatic cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | To find the relation between molecular characteristics of pancreatic cancer and the efficacy of anticancer drugs |
| Basic objectives2 | Others |
| Basic objectives -Others | To find the relation between molecular characteristics of pancreatic cancer and metabolic substances of pancreatic cancer |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | No Primary outcome.Because this study aimed at the accumulation of data and FNA specimen. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | To be able to give informed consent | |||
| Key exclusion criteria | None | |||
| Target sample size | 1000 | |||
| Research contact person | |
| Name of lead principal investigator | Atsuhiro Masuda |
| Organization | Kobe University Hospital |
| Division name | Dep. of Gastroenterology |
| Address | 7-5-1 Kusunoki-cho Chuo-ku Kobe |
| TEL | 078-382-6305 |
| atmasuda@med.kobe-u.ac.jp | |
| Public contact | |
| Name of contact person | Atsuhiro Masuda |
| Organization | Kobe University Hospital |
| Division name | Dep. of Gastroenterology |
| Address | 7-5-1 Kusunoki-cho Chuo-ku Kobe |
| TEL | 078-382-6305 |
| Homepage URL | |
| atmasuda@med.kobe-u.ac.jp | |
| Sponsor | |
| Institute | Division of Gastroenterology, Department of Internal medicine, Kobe University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Division of Gastroenterology, Department of Internal medicine, Kobe University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | The aim of this research is registry of pancreatic cancer performed EUSFNA. Therefore there is no main outcome. In each individual study, we will perform UMIN registration. |
| Other related information | We collected the information of patient's charactaristics, EUSFNA specimens, and serum. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000027885 |